PHDS HEALTHCARE RESEARCH Co., Ltd.
Announcement from the National Medical Products Administration on the Work Related to Food and Drug Supervision During Institutional Reform (Official Reprint)
Release time:
2013-03-22
According to the plan for the reform of the State Council's institutions and the transformation of functions approved by the First Session of the 12th National People's Congress, the responsibilities of the former State Food and Drug Administration have been fully integrated into the newly established National Medical Products Administration. Currently, the work related to institutional reform is being carried out urgently.
According to the reform plan for the State Council's institutions and functions passed by the First Session of the 12th National People's Congress, the responsibilities of the former State Food and Drug Administration have been fully integrated into the newly established National Medical Products Administration. Currently, the relevant institutional reform work is being carried out urgently.
During this period, the various review and approval, inspection and testing, certification inspection, and law enforcement matters related to drug, medical device, cosmetic, health food, and food safety supervision in the catering sector that were previously undertaken by the State Food and Drug Administration will still be handled according to the original regulations. Various permits, certificates, etc. will temporarily continue to use the original format, and the business seals and text formats used will not change for the time being, nor will the handling procedures change. The safety supervision of food production and circulation will continue to follow the original channels until the handover work is completed.
This is a notice.
National Medical Products Administration
March 22, 2013
(PHDS CHINA CRO Registration Declaration)
Keyword:
Relevant regulations and policies
Key points and judgment principles for the quality management of non-clinical research of drugs
In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."
2024-11-22
Technical requirements for the latest declaration data electronic disc
In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.
2024-11-22
In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.
2024-11-22
On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.
2024-11-22

京公网安备11010502056452号